CA2384879C - Nitroimidazole derivative and diagnostic imaging agent containing the same - Google Patents

Nitroimidazole derivative and diagnostic imaging agent containing the same Download PDF

Info

Publication number
CA2384879C
CA2384879C CA2384879A CA2384879A CA2384879C CA 2384879 C CA2384879 C CA 2384879C CA 2384879 A CA2384879 A CA 2384879A CA 2384879 A CA2384879 A CA 2384879A CA 2384879 C CA2384879 C CA 2384879C
Authority
CA
Canada
Prior art keywords
derivative
diagnostic imaging
nitroimidazole
compound
nitroimidazole derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2384879A
Other languages
English (en)
French (fr)
Other versions
CA2384879A1 (en
Inventor
Michihiko Tsujitani
Yoshihiro Takai
Tatsuo Ido
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Pharma Inc
Original Assignee
Pola Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Pharma Inc filed Critical Pola Pharma Inc
Publication of CA2384879A1 publication Critical patent/CA2384879A1/en
Application granted granted Critical
Publication of CA2384879C publication Critical patent/CA2384879C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Hydrogenated Pyridines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyrane Compounds (AREA)
CA2384879A 1999-09-13 2000-09-12 Nitroimidazole derivative and diagnostic imaging agent containing the same Expired - Fee Related CA2384879C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP11/259057 1999-09-13
JP25905799 1999-09-13
JP11/260315 1999-09-14
JP26031599 1999-09-14
PCT/JP2000/006226 WO2001019799A2 (en) 1999-09-13 2000-09-12 Nitroimidazole derivative and diagnostic imaging agent containing the same

Publications (2)

Publication Number Publication Date
CA2384879A1 CA2384879A1 (en) 2001-03-22
CA2384879C true CA2384879C (en) 2010-11-30

Family

ID=26543940

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2384879A Expired - Fee Related CA2384879C (en) 1999-09-13 2000-09-12 Nitroimidazole derivative and diagnostic imaging agent containing the same

Country Status (10)

Country Link
US (1) US6743925B1 (https=)
EP (1) EP1218351B1 (https=)
JP (1) JP4116793B2 (https=)
KR (1) KR100708822B1 (https=)
AT (1) ATE293607T1 (https=)
AU (1) AU6878400A (https=)
CA (1) CA2384879C (https=)
DE (1) DE60019622T2 (https=)
ES (1) ES2237447T3 (https=)
WO (1) WO2001019799A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2841554B1 (fr) * 2002-07-01 2008-01-18 Commissariat Energie Atomique Composes de maleimides marques, leur procede de preparation et leur utilisation pour le marquage de macromolecules
US8257680B1 (en) 2004-02-24 2012-09-04 The General Hospital Corporation Catalytic radiofluorination
US9017724B2 (en) 2004-02-24 2015-04-28 The General Hospital Corporation Catalytic radiofluorination
WO2008090731A1 (ja) * 2007-01-23 2008-07-31 Pola Pharma Inc. ２－ニトロイミダゾール誘導体の製造法
CA2978149C (en) 2008-03-21 2019-02-12 The General Hospital Corporation Inositol derivatives for the detection and treatment of alzheimer's disease and related disorders
JP2012532879A (ja) * 2009-07-07 2012-12-20 ノームオキシーズ，インコーポレイテッド イノシトールトリピロリン酸を使用して多剤耐性を低減する方法
US20120219500A1 (en) 2009-10-26 2012-08-30 Fujifilm Ri Pharma Co., Ltd. Diagnostic agent for infectious diseases
NL1038473C2 (en) * 2010-12-24 2012-06-27 Centre Nat Rech Scient Cancer targeting using carbonic anhydrase isoform ix inhibitors.
ES2569196T3 (es) * 2011-09-22 2016-05-09 ihon Medi-Physics Co., Ltd. Compuesto marcado con flúor radiactivo
CA2959776A1 (en) * 2014-09-25 2016-03-31 Nihon Medi-Physics Co., Ltd. Renal imaging agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0819111B2 (ja) * 1987-10-22 1996-02-28 ポーラ化成工業株式会社 ２―ニトロイミダゾール誘導体及びこれを有効成分とする放射線増感剤
EP0669913B1 (en) * 1992-11-19 2003-03-05 The Trustees Of The University Of Pennsylvania Detection of hypoxia
WO1995009844A1 (en) 1993-10-04 1995-04-13 Board Of Regents, The University Of Texas System Rapid synthesis and use of 18f-fluoromisonidazole and analogs

Also Published As

Publication number Publication date
DE60019622T2 (de) 2006-03-02
WO2001019799A3 (en) 2002-05-10
ES2237447T3 (es) 2005-08-01
WO2001019799A2 (en) 2001-03-22
JP4116793B2 (ja) 2008-07-09
AU6878400A (en) 2001-04-17
ATE293607T1 (de) 2005-05-15
EP1218351B1 (en) 2005-04-20
US6743925B1 (en) 2004-06-01
JP2003509413A (ja) 2003-03-11
DE60019622D1 (de) 2005-05-25
KR20020057955A (ko) 2002-07-12
KR100708822B1 (ko) 2007-04-17
CA2384879A1 (en) 2001-03-22
EP1218351A2 (en) 2002-07-03

Similar Documents

Publication Publication Date Title
KR102008635B1 (ko) 영상화제의 합성 및 사용을 위한 조성물, 방법 및 시스템
EP2753605B1 (en) Compositions, methods, and systems for the synthesis and use of imaging agents
US20240042066A1 (en) Fibroblast activation protein inhibitor
CA2384879C (en) Nitroimidazole derivative and diagnostic imaging agent containing the same
WO2015199205A1 (ja) ２－（３－ピリジニル）－１ｈ－ベンゾイミダゾール誘導体化合物、及び、これを含む医薬
JP7036802B2 (ja) Ｐｅｔ放射性トレーサとしての［１８ｆ］で標識された乳酸誘導体
AU2024343597A1 (en) Dansylamide-modified compounds targeting psma, preparation method therefor, and use thereof
JP5085824B2 (ja) 低酸素の検出のために有用な化合物の製造
US6252087B1 (en) Nitroaromatic compounds for the detection of hypoxia
CN120136958A (zh) Fap靶向放射性药物
EP2712631A1 (en) Radiopharmaceutical products for diagnosis and therapy of renal carcinoma
JP2015110563A (ja) アルドステロン合成酵素阻害剤
US6855828B1 (en) Detection of hypoxia
KR102518936B1 (ko) 베타-아드레날린성 수용체에 특이적인 pet용 추적자
US20050026974A1 (en) Detection of hypoxia
WO2026029180A1 (ja) 放射性トリフェニルピラゾール化合物
JP2015093833A (ja) 放射性ハロゲン標識化合物又はその塩、これを含む医薬
HK40030015B (en) Compositions, methods and systems for the synthesis and use of imaging agents
HK1241356B (zh) 用於合成和使用造影剂的组合物、方法和系统
CN108066776A (zh) 快速成像的坏死心肌显像剂及其制备方法和应用
HK1182933A (en) Compositions, methods and systems for the synthesis and use of imaging agents
HK1182640B (en) Compositions, methods and systems for the synthesis and use of imaging agents
HK1182640A (en) Compositions, methods and systems for the synthesis and use of imaging agents
HK1203941B (en) Compositions, methods, and systems for the synthesis and use of imaging agents

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20190912